1 / 56

Drug Induced Coma & Abusive Drugs

Drug Induced Coma & Abusive Drugs. Dr. ML Tse. Basic Concept. Brain activity = Interplay of neuron depolarization Ion channel activities Voltage-gated IC & Ligand-linked IC Opening / Closing Production / Destruction control by receptor activites. Molecular Basics. Receptors

misae
Download Presentation

Drug Induced Coma & Abusive Drugs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Drug Induced Coma&Abusive Drugs Dr. ML Tse

  2. Basic Concept • Brain activity = Interplay of neuron depolarization • Ion channel activities • Voltage-gated IC & Ligand-linked IC • Opening / Closing Production / Destruction control by receptor activites

  3. Molecular Basics • Receptors • Ligand linked ionophore • G-protein coupled  Cyclase activation  ion channels • Steroid hormone receptors  DNA • Tyrosine kinase receptor (Insulin, growth factors)

  4. Cellular Basics of Neurotransmission • Neurotransmission +/--  Ionophores Na,Ca, K, Cl

  5. Cellular Basics of Neurotransmission • Neuromodulation • Receptor mediated • Non-receptor mediated NO, CO

  6. Basic Neuropharmacology • Amino Acid Transmitters major CNS transmitters • Excitatory • Glutamate (Glu) • Aspartate • Cystate • Homocystate • Inhibitory • -aminobutyric acid (GABA) • Glycine • Taurine • -alanine • Purinoreceptors • Inhibitory • Adenosine

  7. Glutamate Receptors • AMPA (-amino-3-hydroxy-5-methyl-4-isoxazole propionate) • NMDA (N-methyl-D-aspartate) • Kainate • mGlu: Metabotrophic receptor

  8. N-methyl-D-aspartate Receptor

  9. GABAA Receptor

  10. Convulsant Glutamic Acid Glutamate Glutamic acid decarboxylase Pyridoxal Phosphate Hydrazines Isoniazid GABA

  11. Adenosine Receptor • Diffuse CNS Inhibition “Blake” effect • Sleep induction • Endogenous anti-convulsant • xanthines antagonist

  12. Serotonergic Pathways • 5 HT • Midline of pons • locus ceruleus, interpeduncular nucleus • Pacemaker like 1—5 spikes / sec • Inhibitory modulation • 2 systems: fine axons and beaded large axons • Fine 5HT axons damage by MDMA • Pineal gland Raphe pons

  13. NE pathways • Locus Ceruleus in caudal pons • 5 major tracts • ,12, 1 •  Morphine, endorphins, • 2 agonist (clonidine)Firing • Amphetamines, TCA, Opioid withdrawal Firing • Global orientation to external stimuli Locus Ceruleus

  14. Dopaminergic Pathways Putamen caudate • Complex : utra short ; intermediate length; long systems-midbrain to neostriatum and limbic system • D1 – 5 R • Learning behaviour, memory, motor • ?Final common pathway for addiction • Amphetamine, cocaine  antipsychotics  Prefrontal cortex ventral tagamental limbic Substantia nigra

  15. Cholinergic Pathways • Poorly understood • Acetycholine • Diffuse innervation • Cognition, consciouness • Anti-cholinergics, organophosphates • Alzheimer’s ?cholinergic dysfunction

  16. Consciousness Background Arousal Prefrontal cortex Limbic system Hyppocampus Basal Ganglions Efferent Sensory Afferent

  17. Drug Induced Coma • Direct effect on neurons • Receptor mediated • Non-receptor mediated • Secondary Insult due metabolic disturbance • Seizure, coma, death as the final common pathway of intoxication

  18. Management • Decontamination: ?cyanide • ABC, prevent secondary insult • H’stix • History • Toxidrome: • Focal signsCT brain • Opioid, DUMBBELL, Serotonergic, Anti-cholinrgic,etc, convulsants…. • Trial of naloxone • Stable unconscious Vs Unstable Unconscious • ECG: rate, QRS, QTc • Therapeutic use of other antidote • ABG: ?MUDPILE; Osmolar gap, • Lactic acidosis with normal PaCO2 ?cellular asphysants • Panadol level-co-ingestion?1 in 500 • CXR, AXR • ??Urine screening • Supportive

  19. Abusive Substances

  20. Sedative-Hypnotics • Benzodiazepines (since 1955) • GABAA R agonist Cl channel sedative,anxiolytic, muscle relaxing, amnesic • Peripheral benzodiazepine receptors (whole body): mitochondrial outer membrane – adrenal, pituitary, reproductive, heart ; RBC • GHB -hydroxybutyrate (since 1960s) • Bodybuilding, Mood-enhancer, Date-rape • Receptor in basal ganglion •  GH, enkephalin dopamine

  21. Benzos OD • Sleep like toxidrome • Children: ataxia • Paradoxical CNS effects: delirium, psychosis, nightmares with age • Death due to combined overdose • Dx co-ingestion & supportive Mx • Routines screening not helpful: • False –ve: • active metabolites, • triazolam & aprazolam: low active serum concentration • Flunitrazepine, clonazepine –ve immunoessay • +ve result: • Co-ingestion common • Co-morbidity

  22. BenzosOD • Routine flumazenil not recommended • Contraindications: • Seizure Hx • Co-ingestion • Long term user • ECG evidence of TCA • Abnormal vitals • Withdrawal • Anxiety, panic attacks, headache, tremors, paresthesia, seizure

  23. GHB • Toxidrome: cyclical coma:deep coma/agitated episodes, resp depression, rigidity, myoclonus face limbs, bradycardia • Typically pull out the ET tube and fully awake in 6 hrs • Flumazenil not consistent • Withdrawal?

  24. Party Pills

  25. Opioid • Opium, extract of poppy (Papaver somniferum) contains ≥10% morphine • Heroin (diamorphine) since 1874, marketed by Bayer 1898, preferred : euphoric, rush

  26. Opioid Receptors • : euphoria, analgesia, respiration • : miosis, spinal analgesia • : ?analgesia, dopamine nigrostriatal • : not considered as opioid R, • ,: ?? • G-protein linked • Euphoria, addiction : Dopamine release & -R stimulation in mesolimbic system

  27. Clinical Presentation • M & M more due to IV use, cutting agent, contaminant, poor health • Overdose: • Typical toxidrome • Fentanyl: muscle rigidity, urine screen -ve • Dextromethorphan: anti-cholinergic • Methadone: choreoathetosis • pulmonary edema • Direct effect • Neurogenic: acute withdrawal on naloxone, high PaCO2 • Forceful inspiration against closed glottisnegative intrathoric pressure • Withdrawal • Bodypacker

  28. Pitfalls in Mx • Urine immunoessay • +ve codeine, poppy seed • --ve synthetic opioid • Naloxone • Bag-valve mask ventilation • Small incremental dose 0.1mg • Adequate respiration as end-point • Infusion: 2/3 effective bolus / hour

  29. Party Drugs • Amphetamines • LSD • Ketamine • Cocaine • Nematazepam

  30. Clinical Presentation • Acute • Bad trips • Injury • Specific problems related to the substance • Chronic • Poor immune, poor health • Psychiatric: brain damage?

  31. Party Pills • Ecstacy • May or may not contains MDMA • ketamine, MA, barbituate, benzo, panado • Different strength • Unpredictable effect

  32. Trip

  33. Good Trip

  34. Bad Trip

  35. Amphetamines • Speed sulph, uppers, whizz: powder form • Ice: crystalized form of metamphetamine epinephrine amphetamine Methamphetamine

  36. Amphetamines • 179 entries of designer amphetamines Phenylethylamines I Have Known And Loved

  37. Amphetamine • Presynaptic Dopamine and Catecholamine release • Peripheral  and  Sympathomimetic • Central: • NE  Alertness • DA Glu behavioral and psycho • 5-HT (high dose) thermoregulation, psychosis

  38. MDMA( 3,4-methylenedioxymethamphetamine) MDMA serotonin

  39. MDMA • Ecstasy, XTC, Adam • Stimulant(amphetamine) + mild hallucinogenic (weak LSD)

  40. Clinical Presentation • Tweaking

  41. Clinical Presentation • Heat stroke • Intracerebral haemorrhage • Dysrrhythmias • Cerebral infarct • Myocardial ischaemia • Pneumothorax, pneumomediastinum • Hyponatraemia • Rhabdomyolysis • Injury • Fine-5HT neuron damage in braincognitive, psychiatric, behavioral problem

  42. Rx • Benzodiazepine: usually at toxicological dose • Haloperidol • Minimize physical restrain • Cooling

  43. Cocaine • Leaves of coca plant in S. America • Use in religious rituals since 6th century • Identified in 1857 • Add in Coca-cola • >6 Million >12y.o. Americans had tried

  44. Cocaine powder Crack cocaine

  45. Cocaine • Fast Na channel blockage • Catecholamine reuptake inhibition • CNS stimulation: cortexbrain stem • DA reuptake inhibition •  excitatory amino acids • Activemetabolites: benzoylecgonine, norcocaine • More dangerous with alcohol

  46. Clinical Presentation • Hyperthermia • Myocardial ischaemia, dysrhythmia, aortic dissection • ICH, Cerebral infarction, seizures • PneumoT / M, Pulmonary edema • Rhabdomyolysis • Gut ischaemia • Cardiomyopathies

  47. Cocaine • Benzo for agitation, HT • IV Nitrate, phentolamine, morphine,verapamil for ACS • Diltiazem, Verapamil for atrial arrhythmia • NaHCO3, lignocaine, amiodarone for ventricular arrhythmia • Torsade (K channel blocking): MgSO4

  48. Hallucinogens • Lysergamids • LSD: D-lysergic acid diethylamide • Indolealkylamines • Ibogaie • Psilocybin • Phenylethylamines • Mescaline, MDMA • Tetrahydrocannibinoids • Marijunana • Hashish • Anticholinergics • Jimsonweed(Datura stramonium)

More Related